Cargando…
Glomerular filtration rate is the main predictor of urine volume in autosomal dominant polycystic kidney disease patients treated with tolvaptan when daily osmolar excretion is expressed as urinary osmolality/creatinine ratio
Autores principales: | Borrego Utiel, Francisco José, Merino García, Enoc |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7986321/ https://www.ncbi.nlm.nih.gov/pubmed/33777387 http://dx.doi.org/10.1093/ckj/sfaa171 |
Ejemplares similares
-
Glomerular filtration rate and urine osmolality in unilateral ureteropelvic junction obstruction
por: Gheissari, Alaleh, et al.
Publicado: (2013) -
Reference Intervals of Spot Urine Creatinine-to-Osmolality Ratio as a Surrogate of Urinary Creatinine Excretion Rate
por: Hsu, Shih-Ping, et al.
Publicado: (2022) -
Tolvaptan suppresses monocyte chemotactic protein-1 excretion in autosomal-dominant polycystic kidney disease
por: Grantham, Jared J., et al.
Publicado: (2017) -
Paradoxical mortality of high estimated glomerular filtration rate reversed by 24‐h urine creatinine excretion rate adjustment: sarcopenia matters
por: Kao, Pei‐Yu, et al.
Publicado: (2022) -
Sequential changes in urine production, glomerular filtration rate, and electrolyte excretion after mannitol administration
por: Segev, Gilad, et al.
Publicado: (2019)